ENDOMETRIOID ENDOMETRIAL CANCER
Clinical trials for ENDOMETRIOID ENDOMETRIAL CANCER explained in plain language.
Never miss a new study
Get alerted when new ENDOMETRIOID ENDOMETRIAL CANCER trials appear
Sign up with your email to follow new studies for ENDOMETRIOID ENDOMETRIAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo offers hope for hard-to-treat endometrial cancer
Disease control Recruiting nowThis study tests a combination of two drugs, nab-sirolimus and letrozole, in people with advanced or recurrent endometrioid endometrial cancer that cannot be removed by surgery. The goal is to see if the combination shrinks tumors or stops them from growing. About 29 participants…
Matched conditions: ENDOMETRIOID ENDOMETRIAL CANCER
Phase: PHASE2 • Sponsor: Aadi Bioscience, Inc. • Aim: Disease control
Last updated May 01, 2026 15:59 UTC
-
New hope for obese women with endometrial cancer: Weight-Based drug combo trial launches
Disease control Recruiting nowThis early-phase trial tests the safety of combining two drugs, atezolizumab and ONC201, in 58 women with advanced or recurrent endometrial cancer. The study compares how obese and non-obese patients respond to the treatment. The goal is to find the best dose and see if the combi…
Matched conditions: ENDOMETRIOID ENDOMETRIAL CANCER
Phase: PHASE1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Apr 29, 2026 15:02 UTC